Can gastric mucosal intestinal metaplasia be cured?

Feb 06, 2022 Source: Cainiu Health
Dr. Zhang Mingping
Introduction
Intestinal metaplasia of the gastric mucosa can be cured if patients seek timely medical attention and receive standard treatment. Once intestinal metaplasia is diagnosed clinically, regular follow-up gastroscopies and pathological biopsies are essential to detect dysplasia early. If moderate or severe dysplasia develops, preventive measures against gastric cancer must be implemented.

Gastric mucosal intestinal metaplasia—commonly referred to as intestinal metaplasia—is a pathological condition in which the superficial mucosal epithelium of digestive organs (e.g., stomach and intestines) undergoes transformation to resemble intestinal epithelium, typically characterized by the presence of Paneth cells or goblet cells. Can gastric mucosal intestinal metaplasia be cured? The following addresses this question.

Can gastric mucosal intestinal metaplasia be cured?

Yes, gastric mucosal intestinal metaplasia can be effectively treated—and potentially reversed—if diagnosed early and managed appropriately with standardized medical therapy.

Intestinal metaplasia of the gastric mucosa—clinically termed intestinal metaplasia—involves replacement of normal gastric mucosal epithelium by intestinal-type epithelium, marked by the appearance of Paneth cells or goblet cells. It is broadly classified into two major subtypes: focal intestinal metaplasia and mucinous gland intestinal metaplasia. Focal intestinal metaplasia commonly results from chronic inflammatory injury and irritation to the superficial mucosa, as seen in conditions such as chronic gastritis, Helicobacter pylori infection, and bile reflux gastritis. Mucinous gland intestinal metaplasia is more frequently associated with external irritants—including environmental chemical toxins, certain medications, long-term smoking, and excessive alcohol consumption.

Once intestinal metaplasia is identified clinically, regular surveillance via gastroscopy and histopathological biopsy is essential to detect dysplasia at an early stage. Early detection of dysplasia is critical, as moderate-to-severe dysplasia significantly increases the risk of gastric cancer development and warrants preventive intervention. With appropriate treatment—including eradication of H. pylori, anti-inflammatory therapy, and lifestyle modification—the underlying gastric mucosal inflammation may resolve satisfactorily, and intestinal metaplasia may even regress, particularly when the affected area is relatively small.

The above provides an overview of whether gastric mucosal intestinal metaplasia can be cured. We hope this information is helpful to you.